AAAAAA
Results:
1-20
|
Results: 20
Authors:
WONG SL
DRAJESK J
CHANG MS
WITT G
AWNI WM
Citation: Sl. Wong et al., DOSE-PROPORTIONAL PHARMACOKINETICS OF A NEW 5-LIPOXYGENASE INHIBITOR,ABT-761, IN HEALTHY-VOLUNTEERS, Biopharmaceutics & drug disposition, 19(3), 1998, pp. 159-162
Authors:
WONG SL
ODEA RF
DUBE LM
AWNI WM
Citation: Sl. Wong et al., EFFECTS OF ABT-761, A NOVEL 5-LIPOXYGENASE INHIBITOR, ON THE PHARMACOKINETICS OF A SINGLE-DOSE OF ETHINYL ESTRADIOL AND LEVONORGESTREL IN HEALTHY FEMALE VOLUNTEERS, Journal of clinical pharmacology, 38(7), 1998, pp. 642-648
Authors:
WONG SL
DRAJESK J
CHANG M
LANNI C
WITT G
HANSEN R
AWNI WM
Citation: Sl. Wong et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE AND MULTIPLE ORAL DOSES OF A NOVEL 5-LIPOXYGENASE INHIBITOR (ABT-761) IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 63(3), 1998, pp. 324-331
Authors:
KEARNS GL
WONG SL
JOHNSON K
DOWLING P
KEMP JP
DRAJESK J
CHANG M
DUBE L
AWNI WM
Citation: Gl. Kearns et al., PHARMACOKINETICS OF A NOVEL 5-LIPOXYGENASE INHIBITOR (ABT-761) IN PEDIATRIC-PATIENTS WITH ASTHMA, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 80-80
Authors:
WONG SL
ODEA R
DUBE L
AWNI WM
Citation: Sl. Wong et al., STEADY-STATE EFFECT OF ABT-761 ON THE PHARMACOKINETICS OF ETHINYL ESTRADIOL AND LEVONORGESTREL, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 106-106
Authors:
AWNI WM
LOCKE C
DUBE LM
CAVANAUGH JH
Citation: Wm. Awni et al., EVALUATION OF THE DIURNAL-VARIATION IN THE PHARMACOKINETICS OF ZILEUTON IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 37(5), 1997, pp. 388-394
Authors:
AWNI WM
WONG S
CHU SY
PATTERSON K
HANSEN R
MACHINIST JM
DRAJESK J
KEANE WF
HALSTENSON CE
Citation: Wm. Awni et al., PHARMACOKINETICS OF ZILEUTON AND ITS METABOLITES IN PATIENTS WITH RENAL IMPAIRMENT, Journal of clinical pharmacology, 37(5), 1997, pp. 395-404
Authors:
AWNI WM
CAVANAUGH JH
LEESE P
KASIER J
CAO GL
LOCKE CS
DUBE LM
Citation: Wm. Awni et al., THE PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN ZILEUTON AND TERFENADINE, European Journal of Clinical Pharmacology, 52(1), 1997, pp. 49-54
Authors:
WONG SL
CAVANAUGH JH
QIAN J
HANSEN R
AWNI WM
Citation: Sl. Wong et al., EFFECT OF ABT-761 ON THE PHARMACOKINETICS OF THEOPHYLLINE, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 83-83
Authors:
AWNI WM
WONG S
CHU SY
PATTERSON K
HANSEN R
MACHINIST JM
DRAJESK J
KEANE WF
HALSTENSON CE
Citation: Wm. Awni et al., PHARMACOKINETICS OF ZILEUTON AND ITS METABOLITES IN SUBJECTS WITH RENAL IMPAIRMENT, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 90-90
Authors:
WONG SL
CAVANAUGH J
SHI H
AWNI WM
GRANNEMAN GR
Citation: Sl. Wong et al., EFFECTS OF DIVALPROEX SODIUM ON AMITRIPTYLINE AND NORTRIPTYLINE PHARMACOKINETICS, Clinical pharmacology and therapeutics, 60(1), 1996, pp. 48-53
Authors:
AWNI WM
CAO G
KASIER JF
LOCKE CS
MACHINIST JM
DUBE LM
Citation: Wm. Awni et al., THE PHARMACOKINETIC PHARMACODYNAMIC INTERACTION BETWEEN ZILEUTON AND TERFENADINE/, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 61-61
Authors:
FISCHER AR
MCFADDEN CA
FRANTZ R
AWNI WM
COHN J
DRAZEN JM
ISRAEL E
Citation: Ar. Fischer et al., EFFECT OF CHRONIC 5-LIPOXYGENASE INHIBITION ON AIRWAY HYPERRESPONSIVENESS IN ASTHMATIC SUBJECTS, American journal of respiratory and critical care medicine, 152(4), 1995, pp. 1203-1207
Authors:
AWNI WM
HALSTENSON CE
NAYAK RK
OPSAHL JA
DESIRAJU RK
MINN FL
MATZKE GR
Citation: Wm. Awni et al., PHARMACOKINETICS OF BEPRIDIL AND 2 OF ITS METABOLITES IN PATIENTS WITH END-STAGE RENAL-DISEASE, Journal of clinical pharmacology, 35(4), 1995, pp. 379-383
Authors:
AWNI WM
GRANNEMAN GR
LOCKE CS
BRANDWEIN SR
DUBE LM
Citation: Wm. Awni et al., POPULATION PHARMACOKINETICS OF ZILEUTION, A SELECTIVE 5-LIPOXYGENASE INHIBITOR, IN PATIENTS WITH RHEUMATOID-ARTHRITIS, European Journal of Clinical Pharmacology, 48(2), 1995, pp. 155-160
Authors:
STPETER JV
BRAECKMAN RA
GRANNEMAN GR
LOCKE CS
CAVANAUGH JH
AWNI WM
Citation: Jv. Stpeter et al., THE EFFECT OF ZILEUTON ON ANTIPYRINE AND INDOCYANINE GREEN DISPOSITION, Clinical pharmacology and therapeutics, 57(3), 1995, pp. 299-308
Authors:
HIRATADULAS CAI
AWNI WM
MATZKE GR
HALSTENSON CE
GUAY DRP
Citation: Cai. Hiratadulas et al., EVALUATION OF 2 INTRAVENOUS SINGLE-BOLUS METHODS FOR MEASURING EFFECTIVE PENAL PLASMA-FLOW, American journal of kidney diseases, 23(3), 1994, pp. 374-381
Authors:
AWNI WM
HOFF JV
SHAPIRO BE
HALSTENSON CE
Citation: Wm. Awni et al., A DOSE-RANGING PHARMACOKINETICS STUDY OF SODIUM DIETHYLDITHIOCARBAMATE IN NORMAL HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 34(12), 1994, pp. 1183-1190
Authors:
AWNI WM
CAVANAUGH JH
GRANNEMAN GR
SCHNECK DW
DUBE LM
Citation: Wm. Awni et al., DIURNAL-VARIATION IN THE PHARMACOKINETICS OF ZILEUTON IN HUMANS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 199-199
Authors:
RAILKAR AM
AWNI WM
CAMP RJ
RAHMAN YE
Citation: Am. Railkar et al., STUDIES ON AN ORAL IRON CHELATOR - 1,2-DIMETHYL-3-HYDROXY-PYRID-4-ONE(DMHP) - MECHANISM OF INTESTINAL-ABSORPTION IN RABBITS, Journal of Pharmacy and Pharmacology, 45(5), 1993, pp. 400-405
Risultati:
1-20
|